Number of the records: 1
Antitubercular nanocarrier monotherapy: study of in vivo efficacy and pharmacokinetics for rifampicin
- 1.Trousil, Jiří - Pavliš, O. - Kubíčková, P. - Škorič, M. - Marešová, V. - Pavlova, Ewa - Knudsen, K. D. - Dai, Y.-S. - Zimmerman, M. - Dartois, V. - Fang, J.-Y. - Hrubý, Martin
Antitubercular nanocarrier monotherapy: study of in vivo efficacy and pharmacokinetics for rifampicin.
Journal of Controlled Release. Roč. 321, 10 May (2020), s. 312-323. ISSN 0168-3659. E-ISSN 1873-4995
OECD category: Polymer science
Impact factor: 9.776, year: 2020
Method of publishing: Limited access
https://www.sciencedirect.com/science/article/pii/S0168365920301164?via%3Dihub
http://hdl.handle.net/11104/0307136
Number of the records: 1